NASDAQ: DYAI - Dyadic International, Inc.

Доходность за полгода: -48.17%
Сектор: Healthcare

График акции Dyadic International, Inc.


О компании

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. It utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus-like particles, protein antigens, ferritin nanoparticles, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins.

Подробнее
The company offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to demonstrate the safety in humans of a protein produced from C1-cell protein production platform. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; and strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U., as well as co-development and marketing agreement with Fermbox Bio Inc to design, Develop, and commercialize animal free alternative proteins and biomaterials The company was founded in 1979 and is headquartered in Jupiter, Florida.

Выручка 0.0017
EBITDA -0.0092
Число акций ао 0.0288 млрд
P/S 82.57
P/BV 3.87
EV/EBITDA -14.52
Цена ао 1.58
ISIN US26745T1016
Сайт https://www.dyadic.com
Валюта usd
IPO date 2004-11-05
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Изменение цены за день: +0.5076% (0.985)
Изменение цены за неделю: -10% (1.1)
Изменение цены за месяц: -22.05% (1.27)
Изменение цены за 3 месяца: -29.29% (1.4)
Изменение цены за полгода: -48.17% (1.91)
Изменение цены за год: -51.47% (2.04)
Изменение цены за 3 года: -82.72% (5.73)
Изменение цены за 5 лет: -83.77% (6.1)
Изменение цены с начала года: -42.11% (1.71)

Недооценка

Название Значение Оценка
P/S 15.6 1
P/BV 7.69 1
P/E 0 0
EV/EBITDA -4.74 0
Итого: 3.5

Эффективность

Название Значение Оценка
ROA, % -82.68 0
ROE, % -115.6 0
Итого: 0

Дивиденды

Название Значение Оценка
Div yield, % 0 0
DSI 0 0
Итого: 0

Долг

Название Значение Оценка
Debt/EBITDA -0.0167 10
Итого: 9.8

Импульс роста

Название Значение Оценка
Доходность Revenue, % 70.52 8
Доходность Ebitda, % -10.96 0
Доходность EPS, % -23.31 0
Итого: 2.2

Институционалы Объем Доля, %
Bandera Partners LLC 1566908 5.87
Chapin Davis, Inc. 826301 3.09
Vanguard Group Inc 803917 3.01
Northeast Financial Consultants Inc 250000 0.94
Blackrock Inc. 248614 0.93
Geode Capital Management, LLC 222696 0.83
Sage Mountain Advisors, LLC 106564 0.4
Northern Trust Corporation 77115 0.29
State Street Corporation 56550 0.21
Susquehanna International Group, LLP 48626 0.18

ETF Доля, % Доходность за год, % Дивиденды, %
iShares Micro-Cap ETF 0.00722 35.054312164247 1.54048



Руководитель Должность Оплата Год рождения
Mr. Mark A. Emalfarb Founder, CEO, President & Director 874.37k 1956 (68 лет)
Ms. Ping Wang Rawson CPA, M.B.A. Chief Financial Officer 348.42k 1976 (48 лет)
Mr. Joseph P. Hazelton Chief Operating Officer 358.12k 1976 (48 лет)
Mr. Doug Pace B.A. Executive Vice President of Business Development N/A
Ms. Ana Gómez Rodriguez Secretary of the Board N/A

Адрес: United States, Jupiter. FL -, 1044 North U.S. Highway One - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.dyadic.com